![](/img/cover-not-exists.png)
Effect of the new dopaminergic agonist CV 205–502 on plasma prolactin levels and tumour size in bromocriptine-resistant prolactinomas
L. Duranteau, P. Chanson, A. Lavoinne, S. Horlait, J. Lubetzki, J. M. KuhnVolume:
34
Year:
1991
Language:
english
Pages:
5
DOI:
10.1111/j.1365-2265.1991.tb01731.x
File:
PDF, 392 KB
english, 1991